UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000715
Receipt number R000000850
Scientific Title Japanese randomized control Study of warm Total Arch Replacement
Date of disclosure of the study information 2007/05/11
Last modified on 2009/10/05 12:32:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Japanese randomized control Study of warm Total Arch Replacement

Acronym

JSTAR-II

Scientific Title

Japanese randomized control Study of warm Total Arch Replacement

Scientific Title:Acronym

JSTAR-II

Region

Japan


Condition

Condition

Patients undergoing total arch replacement without any additional cardiac procedures.

Classification by specialty

Vascular surgery Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The object of JSTAR-II study is to evaluate the safety and the efficiency of total arch replacement under moderate hypothermia.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II,III


Assessment

Primary outcomes

The primary parameter for the evaluation of the study is the total volume of transfusion.

Key secondary outcomes

The other parameters for the evaluation of the study are operative death, neurological complications, cardiac complications, respiratory complications, renal complications, amount of bleeding, and infectious complications.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Group of 28 deg C : Temperature at bladder should be 28 plus minus 2 deg C, and the perfusion pressure of SCP should be over 50mmHg.

Interventions/Control_2

Group of 20 deg C : Temperature at bladder should be 20 plus minus 2 deg C, and the perfusion pressure of SCP should be between 30 and 50mmHg.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Patients undergoing total arch replacement without any additional cardiac procedures.
All operative procedures can be possible through median sternotomy.

Key exclusion criteria

1) Emergency cases
2) Extended aneurysms, i.e., existence of concomitant root, descending, thoracoabdominal, abdominl aneurysms.
3) Patients with severe atheromatous lesion.
4) Atypical aortic diseases, i.e., Takayasu disease, Behcet disease, Marfan syndrome, Ehlers-Danlos syndrome.
5) Severe grade of arteriosclerosis obliterans.
6) Re-sternotomy cases
7) Abnormality of neurological, cardiac, respiratory, hepatic, renal, hematological functions.
8) Infections
9) Cancer-bearing patients.
10) Mental diseases, including dementia.
11) Other improper patients judged by physician-in-charge

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hitoshi Ogino

Organization

National Cardiovascular Center

Division name

Department of Cardiovascular Surgery

Zip code


Address

5-7-1Fujishiro-dai, Suita, Osaka, Japan

TEL

06-6833-5012

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hitoshi Ogino

Organization

National Cardiovascular Center

Division name

Department of Cardiovascular Surgery

Zip code


Address

5-7-1Fujishiro-dai, Suita, Osaka, Japan

TEL

06-6833-5012

Homepage URL


Email

hogino@hsp.ncvc.go.jp


Sponsor or person

Institute

National Cardiovascular Center

Institute

Department

Personal name



Funding Source

Organization

Japanese Ministry of Health,Labor,and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 05 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 03 Month 30 Day

Date of IRB


Anticipated trial start date

2007 Year 05 Month 01 Day

Last follow-up date

2009 Year 09 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2007 Year 05 Month 10 Day

Last modified on

2009 Year 10 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000850


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name